T-cell clones of uncertain significance. When is the rogue clone dangerous?


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
03 Oct 2024
Historique:
received: 10 06 2024
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 4 10 2024
Statut: aheadofprint

Résumé

T cell large granular lymphocyte clones that persist over time and that exhibit molecular and immunophenotypic features closely resembling those of T-cell Large Granular Lymphocyte Leukemia (T-LGLL) may be detectable in individuals who lack any clinical or laboratory features supporting a diagnosis of T-cell malignancy. This condition represents a potential precursor state termed T cell clones of uncertain significance (T-CUS). T-CUS represents the even more benign extreme of the wide spectrum of clonal T- large granular lymphocyte proliferations, emphasizing the need for an appropriate multiparametric diagnostic assessment that avoids misdiagnosis of T-cell neoplasia. This approach should overcome the numerical cut-offs as the sole criteria to differentiate the benign condition from the related malignancies. In particular, genomic aberrancies might prospectively identify individuals who are at risk of progression to full blown T-cell malignancy. We herein discuss the significance of these T cell clones in both healthy and disease states suggesting molecular assays for tracking early steps of disease.

Identifiants

pubmed: 39363880
doi: 10.3324/haematol.2024.286023
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Gianpietro Semenzato (G)

University of Padova, Department of Medicine, Hematology Unit; Veneto Institute of Molecular Medicine, Padova. g.semenzato@unipd.it.

Antonella Teramo (A)

University of Padova, Department of Medicine, Hematology Unit; Veneto Institute of Molecular Medicine, Padova.

Giulia Calabretto (G)

University of Padova, Department of Medicine, Hematology Unit; Veneto Institute of Molecular Medicine, Padova.

Renato Zambello (R)

University of Padova, Department of Medicine, Hematology Unit; Veneto Institute of Molecular Medicine, Padova.

Classifications MeSH